| Single-dose liposomal amphotericin B treatment for cryptococcal meningitis JN Jarvis, DS Lawrence, DB Meya, E Kagimu, J Kasibante, E Mpoza, ... New England Journal of Medicine 386 (12), 1109-1120, 2022 | 217 | 2022 |
| High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV)-positive Ugandan adults: a phase II … FV Cresswell, DB Meya, E Kagimu, D Grint, L Te Brake, J Kasibante, ... Clinical Infectious Diseases 73 (5), 876-884, 2021 | 69 | 2021 |
| Tuberculosis IRIS: pathogenesis, presentation, and management across the spectrum of disease CM Quinn, V Poplin, J Kasibante, K Yuquimpo, J Gakuru, FV Cresswell, ... Life 10 (11), 262, 2020 | 67 | 2020 |
| Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics PS Ramachandran, A Ramesh, FV Creswell, A Wapniarski, R Narendra, ... Nature communications 13 (1), 1675, 2022 | 59 | 2022 |
| Cryptococcal meningitis L Tugume, K Ssebambulidde, J Kasibante, J Ellis, RM Wake, J Gakuru, ... Nature Reviews Disease Primers 9 (1), 62, 2023 | 41 | 2023 |
| Oral lipid nanocrystal amphotericin B for cryptococcal meningitis: a randomized clinical trial DR Boulware, M Atukunda, E Kagimu, AK Musubire, A Akampurira, ... Clinical Infectious Diseases 77 (12), 1659-1667, 2023 | 29 | 2023 |
| Standardized urine-based tuberculosis (TB) screening with TB-lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan adults with advanced human immunodeficiency virus disease and … FV Cresswell, J Ellis, E Kagimu, AS Bangdiwala, M Okirwoth, G Mugumya, ... Open forum infectious diseases 7 (4), ofaa100, 2020 | 29 | 2020 |
| Evaluation of the Dynamiker cryptococcal antigen lateral flow assay for the diagnosis of HIV-associated cryptococcosis R Kwizera, D Omali, K Tadeo, J Kasibante, MK Rutakingirwa, E Kagimu, ... Journal of clinical microbiology 59 (3), 10.1128/jcm. 02421-20, 2021 | 27 | 2021 |
| Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis … DS Lawrence, C Muthoga, DB Meya, L Tugume, D Williams, ... The Lancet Global Health 10 (12), e1845-e1854, 2022 | 21 | 2022 |
| High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study) S Marais, FV Cresswell, RL Hamers, LHM Te Brake, AR Ganiem, D Imran, ... Wellcome open research 4, 190, 2020 | 20 | 2020 |
| Diagnosis and management of cryptococcal meningitis in HIV-infected adults TC McHale, DR Boulware, J Kasibante, K Ssebambulidde, CP Skipper, ... Clinical microbiology reviews 36 (4), e00156-22, 2023 | 16 | 2023 |
| Outpatient cryptococcal antigen screening is associated with favorable baseline characteristics and improved survival in persons with cryptococcal meningitis in Uganda AE Levin, AS Bangdiwala, E Nalintya, E Kagimu, J Kasibante, ... Clinical Infectious Diseases 76 (3), e759-e765, 2023 | 15 | 2023 |
| Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? E Kagimu, N Engen, K Ssebambulidde, J Kasibante, TK Kiiza, E Mpoza, ... Open Forum Infectious Diseases 9 (9), ofac416, 2022 | 15 | 2022 |
| Association of hyponatremia on mortality in cryptococcal meningitis: a prospective cohort L Tugume, A Fieberg, K Ssebambulidde, E Nuwagira, DA Williams, ... Open Forum Infectious Diseases 9 (7), ofac301, 2022 | 10 | 2022 |
| Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra polymerase chain reaction cycle threshold value predicts 2-week mortality in human immunodeficiency virus–associated … EM Martyn, AS Bangdiwala, E Kagimu, MK Rutakingirwa, J Kasibante, ... Clinical Infectious Diseases 73 (9), e3505-e3510, 2021 | 10 | 2021 |
| Single high-dose liposomal amphotericin based regimen for treatment of HIV-associated Cryptococcal Meningitis: results of the phase-3 Ambition-cm Randomised Trial. DS Lawrence, DB Meya, E Kagimu, J Kasibante, E Mpoza, ... Journal of the International AIDS Society 24 (S4), 70-72, 2021 | 9 | 2021 |
| Diagnostic and prognostic value of cerebrospinal fluid lactate and glucose in HIV-associated tuberculosis meningitis E Nuwagira, K Huppler Hullsiek, S Jjunju, M Rutakingirwa, J Kasibante, ... Microbiology Spectrum 10 (4), e01618-22, 2022 | 8 | 2022 |
| Tuberculosis preventive therapy (TPT) to prevent tuberculosis co-infection among adults with HIV-associated cryptococcal meningitis: a clinician’s perspective J Kasibante, MK Rutakingirwa, E Kagimu, K Ssebambulidde, J Ellis, ... Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 20, 100180, 2020 | 8 | 2020 |
| Baseline serum C-reactive protein level predicts mortality in cryptococcal meningitis S Chesdachai, NW Engen, J Rhein, L Tugume, T Kiiza Kandole, M Abassi, ... Open Forum Infectious Diseases 7 (12), ofaa530, 2020 | 6 | 2020 |
| 869. Oral encochleated amphotericin B for cryptococcal meningitis: a phase II randomized trial M Atukunda, E Kagimu, MK Rutakingirwa, L Tugume, L Nsangi, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 062, 2022 | 4 | 2022 |
David MeyaAssociate Professor, College of Health Sciences, Makerere University; Adjunct Associate ProfessorAdresse e-mail validée de mak.ac.ug
